Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-03-10 Sale | 2021-03-12 8:00 pm | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 1,048 | $34.95 | $36,631 | 92,854 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-01 Option Award | 2022-02-03 4:33 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director | 3,882 | $0 | 25,960 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:30 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 74 | $13.94 | 36,407 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 5:03 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director | 2,000 | $0 | 22,078 (Direct) | View |
| 2021-12-10 Option Award | 2021-12-10 8:03 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director | 4,216 | $0 | 20,078 (Direct) | View |
| 2021-08-31 Exercise | 2021-09-02 8:00 pm | N/A 2028-12-11 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 4,900 | $0 | 113,933 (Direct) | View |
| 2021-08-31 Exercise | 2021-09-02 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 4,900 | $15 | 113,933 (Direct) | View |
| 2021-07-06 Option Award | 2021-07-08 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 454 | $29.49 | 31,433 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 8:00 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 2,500 | $0 | 92,854 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 8:00 pm | N/A 2031-03-09 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 56,875 | $0 | 92,854 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 5:06 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 48 | $30.92 | 29,527 (Direct) | View |
| 2020-07-02 Option Award | 2020-07-06 7:44 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 488 | $30.66 | 29,479 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-11 8:33 pm | N/A 2030-03-09 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 52,500 | $0 | 52,500 (Direct) | View |
| 2019-12-12 Option Award | 2020-02-14 5:00 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Polverino Anthony J. Director | 5,071 | $0 | 15,862 (Direct) | View |
| 2020-01-08 Option Award | 2020-01-09 4:06 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 371 | $19.54 | 28,991 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-13 4:17 pm | N/A 2028-12-11 | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 27,500 | $0 | 111,120 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-13 4:17 pm | N/A N/A | Zymeworks Inc. | ZYME | Polverino Anthony J. Chief Scientific Officer | 27,500 | $15 | 111,120 (Direct) | View |